A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleA Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsTyler J Curiel